Assessing the impact of Chronic Pulmonary Aspergillosis on health and well-being
Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
This study is trying to create a new questionnaire to help understand how Chronic Pulmonary Aspergillosis affects the daily lives of patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Imperial College London Academic / other |
| Locations | 3 sites (Dundee and 2 other locations) |
| Trial ID | NCT06885905 on ClinicalTrials.gov |
What this trial studies
This study aims to develop and validate a new questionnaire specifically designed to measure health-related quality of life (HRQoL) in patients suffering from Chronic Pulmonary Aspergillosis (CPA). By focusing on the unique challenges faced by these patients, the CPA-HAQ questionnaire will be utilized in clinical research and trials to better understand the disease's impact on daily living. The study will involve patients who meet specific eligibility criteria, including age and diagnosis, to ensure accurate data collection and analysis.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with Chronic Pulmonary Aspergillosis and can provide informed consent.
Not a fit: Patients who do not speak or understand English may not benefit from this study due to the language requirements for participation.
Why it matters
Potential benefit: If successful, this study could provide a valuable tool for assessing the quality of life in CPA patients, leading to improved patient care and treatment strategies.
How similar studies have performed: While this approach is focused on developing a specific questionnaire, similar studies have successfully validated disease-specific HRQoL measures in other conditions, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. All patients \>/= 18 years old and able to provide informed consent 2. Patients with a diagnosis of chronic pulmonary aspergillosis 3. To speak and understand English 4. Able to provide informed consent
Where this trial is running
Dundee and 2 other locations
- Ninewells Hospital & Medical School — Dundee, United Kingdom (Recruiting)
- Imperial College London — London, United Kingdom (Recruiting)
- Manchester NHS Foundation Trust — Manchester, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Dareen Marghlani, MSc
- Email: dsm20@ic.ac.uk
- Phone: dsm20@ic.ac.uk
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.